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Key questions
What is already known about this subject?
 ► More than 50% of all patients with chest pain pre-
senting at the emergency department have non-car-
diac chest pain (NCCP).
 ► Due to the heterogeneous nature of NCCP and its in-
herent diagnostic challenges, patients are frequent-
ly undergoing overinvestigation resulting in stress 
and high costs.
What does this study add?
 ► Our study compares the mortality, major adverse 
cardiac events (MACE) and diagnostic healthcare 
consumption of NCCP with patients with cardiac 
chest pain (CCP).
 ► We show that NCCP is more prevalent than CCP and 
despite the good nature of NCCP, the use of health-
care is substantial.
 ► Patients with NCCP do frequently have a history of 
coronary artery disease and a high presence of car-
diovascular risk factors.
How might this impact on clinical practice?
 ► Triage during the first presentation with chest pain 
should be improved to minimise unnecessary hos-
pital admissions and the consequential healthcare 
utilisation of patients with NCCP while still prevent-
ing MACE.
AbstrAct
Objective Presentations of non-cardiac chest pain 
(NCCP) to the emergency department (ED) are increasing. 
More knowledge of prognosis and healthcare utilisation 
of patients with NCCP is necessary to optimise their 
management.
Methods This study is a prospective, observational, 
prevalence-based cohort study conducted from September 
2015 to February 2016 with 1-year follow-up including 
all patients 18 years and older referred to the ED with 
chest pain. Discharge diagnoses, mortality, major adverse 
cardiac events (MACE), re-presentations to the ED, 
hospitalisations, cardiac interventions and outpatient 
monitoring were assessed.
Results More than 60% of the 1239 patients presenting 
with chest pain were discharged with NCCP. The all-cause 
1-year mortality rate of patients with NCCP was 2.3% 
compared with 7.2% in patients with cardiac chest pain 
(CCP) (p<0.001) and the occurrence of MACE was 5.1% vs 
8.3%, respectively (p=0.026). Previous history of coronary 
artery disease (CAD) in patients with NCCP was identified 
as a predictive factor for MACE (OR 4.30 (95% CI 1.24 
to 14.89), p=0.021). Patients with NCCP had more non-
invasive interventions than patients with CCP (proportion 
of 0.225 vs 0.165 per patient, p<0.001) and 13.7% of 
patients with NCCP re-presented at the ED within 1  year.
Conclusion The majority of patients referred to the ED 
with chest pain are discharged with NCCP. The prognosis 
of patients with NCCP is better than patients with CCP; 
however, they are at risk for MACE due to a history of CAD. 
Patients with NCCP moreover use a substantial amount of 
medical resources, stressing the importance of good triage 
to minimise unnecessary healthcare utilisation while still 
preventing MACE.
IntROduCtIOn
Non-cardiac chest pain (NCCP) has grown 
in clinical significance both in primary and 
secondary healthcare. There has been an 
increase in admissions with NCCP over the 
past decades, whereas the amount of presenta-
tions with acute coronary syndrome (ACS) 
has decreased.1 Population-based studies 
have estimated the prevalence of NCCP to 
range between 23% and 33%,1 2 accounting 
for 2%–5% of all emergency presentations 
and more than 50% of all chest pain cases 
presenting at the emergency department 
(ED).1 3 Due to the heterogeneous nature 
of the condition, diagnosing the underlying 
cause of NCCP is challenging.1 4 5 NCCP is 
defined as chest pain not attributed to under-
lying ischaemic heart disease and may be of 
gastrointestinal, musculoskeletal, respiratory 
or psychological origin.1 3 4 6 Moreover, there 
may be an overlap in the underlying condi-
tions causing NCCP.1 As a consequence of 
these diagnostic challenges, the cost of NCCP 
has increased tremendously.1 In addition, 
there is a considerable persistence of symp-
toms resulting in continued utilisation of 
medical resources, with signs of overinvesti-
gation in every 10th patient with persisting 
chest pain, despite the good prognosis.1 7
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The primary aim of this study is to gain insight into 
the prognosis of patients with NCCP presenting at the ED 
compared with patients with cardiac chest pain (CCP), 
in terms of mortality and occurrence of major adverse 
cardiac events (MACE). Second, the study aims to iden-
tify baseline variables in patients with NCCP that increase 
the risk for developing a MACE. Finally, it provides an 
overview of the utilisation of secondary healthcare at the 
cardiology department by patients with chest pain. These 
insights will contribute to the optimal management of 
patients with NCCP.
MetHOds
study design
This study is a prospective, observational, prevalence-based 
cohort study conducted from the 1 September 2015 to 28 
February 2016 with a year follow-up until the 28 February 
2017.
study sample and setting
All patients 18 years or older with chest pain who were 
referred to the ED suspected of ACS were included in this 
study. This included all patients with non-traumatic chest 
pain and other symptoms that can rise the suspicion of 
ACS. This study investigated patients referred from 
outside the hospital and thus excluded patients referred 
by specialists. The ED is located at VieCuri Medical 
Centre, a medium-sized teaching hospital and an off-site 
percutaneous coronary intervention (PCI) centre in the 
Netherlands.
data collection
Data were collected by the attending physician and 
retrieved through medical files. A questionnaire was given 
to patients with additional questions not readily available 
in the medical files to minimise missing data. Collected 
data included demographics, history, symptoms, medi-
cation, discharge diagnosis made by the attending physi-
cian, mortality, occurrence of MACE, re-presentations at 
the ED, hospitalisations and cardiac interventions.
Ethical approval was waived by Medical Ethical Review 
Commission Utrecht, protocol number 15/382.
data analysis
Statistical analyses were performed using IBM SPSS V.24. 
Descriptive statistics are summarised as proportions for 
categorical variables and mean with SD for continuous 
variables. Comparison between patients with NCCP and 
CCP was performed using the Students-t-test, Mann 
Whitney U test or χ² test, as appropriate. Possible factors 
in the NCCP subset related to the occurrence of MACE 
were investigated using logistic regression analysis. 
Factors with a p-value<0.10 in univariate models were 
considered for further investigation by means of a multi-
variate model and expressed as ORs and 95% CIs. P<0.05 
was considered to be statistically significant. Patients with 
missing values were included, with exception of their 
missing values.
definitions
Patients with CCP included patients with ACS and non-is-
chaemic heart disease. ACS was subdivided as ST-elevation 
myocardial infarction (STEMI), non-STEMI (NSTEMI) 
or unstable angina pectoris (UAP).8 Non-ischaemic heart 
disease included (myo-)pericarditis, heart rhythm prob-
lems, valvular disease and cardiomyopathies.
NCCP was defined as chest pain not attributed to 
underlying (ischaemic) heart disease and subdivided in 
NCCP of known origin (NCCP-K) and NCCP of unknown 
origin (NCCP-U). NCCP-K comprised patients who were 
discharged from the index admission with a non-car-
diac diagnosis for their chest pain. This group included 
severe conditions such as pneumonia, pulmonary embo-
lism, pneumothorax, aortic dissection and severe gastro-
intestinal disorders and also benign conditions such as 
gastro-oesophageal reflux disease, musculoskeletal disor-
ders and psychological disorders. NCCP-U are patients 
who were discharged with chest pain not otherwise 
specified.
MACE included any STEMI, NSTEMI, UAP, PCI and 
coronary artery bypass grafting (CABG) after discharge. 
An ACS diagnosis and its corresponding treatment at 
initial admission was not considered a MACE.8
Results
During the study period, 1322 patients, with a total of 1469 
presentations, were referred to the ED with suspected 
ACS. Patients referred by specialists (n=66) and patients 
who were referred with an out-of-hospital cardiac arrest 
(n=17) were excluded from further analysis. There were 
25 patients lost to follow-up due to them not living in 
the Netherlands or due to an unknown general practi-
tioner (GP). GPs referred 1001 (80.8%) patients and the 
remaining 238 (19.2%) patients were referred by emer-
gency medical transport or were self-referrals. CCP was 
diagnosed in 490 (39.5%) patients and NCCP in 749 
(60.5%) patients. Further differentiations are shown in 
figure 1.
Baseline characteristics
Characteristics at baseline differed between the 
patients with NCCP and CCP/ACS in mean age (60.6 
vs 66.1/66.6 years, p<0.001/p<0.001), male gender 
(45.3% vs 66.5/66.8%, p<0.001/p<0.001) and history of 
hypercholesterolemia (39.3% vs 47.6/49.1%, p=0.004/
p=0.003). Baseline differences between patients with 
NCCP and CCP (but not patients with ACS) were 
seen for cardiovascular disease (CVD) (42.9% vs 48.6, 
p=0.048) and coronary artery disease (CAD) (29.1% vs 
35.8%, p=0.014) (online supplementary table 1). The 
NCCP-K and NCCP-U subsets did not differ in base-
line characteristics, with the exception of history of 
CVD (37.4% vs 47.8%, p=0.004) and CAD (23.9% vs 
33.9%, p=0.003), which were both more prevalent in 
the NCCP-U subset.
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Figure 1 Study flow chart and diagnosis at discharge from ED. ACS, acute coronary syndrome; CCP, cardiac chest pain; 
ED, emergency department; EMT, emergency medical transport; GI: gastrointestinal disorders; GP, general practitioner, NCCP, 
non-CCP; NCCP-K, NCCP of known origin; NCCP-U, NCCP of unknown origin; NSTEMI, non-STEMI; STEMI, ST-elevated 
myocardial infarction; UAP, unstable angina pectoris.
Changes in discharge diagnosis during 1-year follow-up
A number of the initial diagnoses were revised within the 
1-year follow-up. In the patients with ACS, all STEMI and 
NSTEMI diagnoses remained unchanged, whereas 74.6% 
of the UAP diagnoses remained the same. In the latter 
group, 9 (15.2%) patients received a diagnosis of non-is-
chaemic heart disease and 6 (10.2%) diagnoses became 
NCCP-K. In the group of patients with chest pain caused 
by non-ischaemic heart disease, 145 (88.0%) diagnoses 
remained unchanged and the remaining cases were 
adjusted into ACS (0.6%), NCCP-K (1.2%) and NCCP-U 
(10.2%). In the NCCP-K group, 6 (1.7%) diagnoses 
were adjusted into non-ischaemic heart disease and 136 
(38.2%) diagnoses into NCCP-U, when all other diag-
noses were excluded. The remaining 215 (60.4%) diag-
noses remained NCCP-K.
The majority of the NCCP-U diagnoses, namely 336 
(85.5%), remained unchanged. Of the remaining 
patients, 2 (0.5%) diagnoses were adjusted into UAP, 31 
(7.9%) into non-ischaemic heart disease and 24 (6.1%) 
into NCCP-K.
Prognosis
A total of 52 patients died during the follow-up of 1 year. 
Kaplan-Meier survival plots are presented in figure 2 and 
mortality rates per group are summarised in table 1.
Patients with CCP had a 1-year mortality rate of 7.2% and 
patients with ACS of 8.1%, both higher compared with the 
NCCP group with a 1-year mortality rate of 2.3% (p<0.001).
The occurrence of MACE during follow-up was higher in 
the CCP and ACS groups compared with the NCCP group 
(8.3% and 8.7% vs 5.1%, respectively, p=0.026) as portrayed 
in table 2. There was no difference between NCCP-K and 
NCCP-U subsets in the occurrence of MACE, except for the 
incidence of UAP which was more frequent in the NCCP-U 
subset (0.0% vs 1.3%, p=0.04). We also analysed the effect 
of a known history of CAD in the NCCP-U subset. The most 
striking difference was found in the occurrence of MACE 
(15.3% with known CAD vs 1.6% without, p<0.001). This 
was also seen when comparing patient with known CVD 
and without CVD (occurrence of MACE in 10.8% vs 2.0%, 
p<0.001). The mortality did not differ in patients with 
NCCP-U with or without CAD or CVD.
Possible predictors for the occurrence of MACE in the 
NCCP group were analysed. After correction for possible 
confounders, we identified one predictor, namely a 
history of CAD (OR 4.30 (95% CI 1.24 to 14.89), p=0.021) 
as shown in online supplementary table 2.
utilisation of secondary healthcare in the cardiology 
department
Table 3 shows the utilisation of secondary healthcare in 
the cardiology department during the 1-year follow-up 
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Figure 2 (A) Survival in CCP group compared to non-CCP (NCCP) of known (K) and unknown (U) origin; CCP vs NCCP, 
p<0.001 (log-rank test); NCCP-K vs NCCP-U p=0.41 (log-rank test). (B) Survival in the ACS group compared to the NCCP 
group; p<0.001 (log-rank test). ACS, acute coronary syndrome; CCP, cardiac chest pain.
Table 1 Mortality rate
Diagnosis at discharge P values 
CCP*
(n=490)
ACS
(n=325)
NCCP†
(n=749)
NCCP-K
(n=356)
NCCP-U
(n=393)
CCP vs 
NCCP
ACS vs 
NCCP
NCCP-K vs 
NCCP-U
In-hospital mortality rate, n (%) 10 (2.0) 9 (2.8) 4 (0.5) 2 (0.6) 2 (0.5) 0.014 0.002 0.921
6-month mortality rate, n (%)‡ 27 (5.6) 22 (6.8) 10 (1.4) 3 (0.9) 7 (1.8) <0.001 <0.001 0.263
1-year mortality rate, n (%)‡ 35 (7.2) 26 (8.1) 17 (2.3) 6 (1.7) 11 (2.9) <0.001 <0.001 0.306
*CCP group includes patients with ACS.
†NCCP group is a sum of the patients of the NCCP-K and NCCP-U groups.
‡7, 6, 9 and 9 patients loss of follow-up in the CCP, ACS, NCCP-K and NCCP-U groups, respectively.
ACS, acute coronary syndrome; CCP, cardiac chest pain; NCCP, non-CCP; NCCP-K, NCCP of known origin; NCCP-U, NCCP of unknown 
origin.
after discharge from the index admission. Patients 
with CCP had a higher utilisation of medical resources 
compared with patients with NCCP. The duration of 
rehospitalisation of patients with NCCP at the cardiology 
department was however similar to that of patients with 
CCP and a proportion of 13.7% of patients with NCCP 
re-presented at the ED.
Patients of the NCCP-U subset had a longer duration 
of hospitalisation, more re-presentations at the ED, more 
rehospitalisation, more outpatient department visits, 
more consultations by phone and a longer outpatient 
department monitoring than the NCCP-K subset.
Cardiac interventions
We analysed the amount of interventions performed 
within the patient groups (online supplementary table 
3). We present proportions as some patients have under-
gone more than one intervention within the follow-up 
period. Patients with CCP and in particular patients 
with ACS underwent more PCIs or CABG (0.598/0.862 
vs 0.047, p<0.001/p<0.001) and more coronary angiog-
raphy (CAG) without intervention (0.251/0.218 vs 0.119, 
p<0.001/p<0.001) than patients with NCCP. Patients with 
NCCP and in particular patients with NCCP-U under-
went more non-invasive interventions such as CT-scans, 
SPECT or MRI’s (0.165 in CCP group vs 0.290 in NCCP 
group, p<0.001 and 0.349 in NCCP-U group, p<0.001). 
The NCCP group was the group with the most patients 
without any intervention (24.7% in CCP group, 39.5% in 
NCCP group, p<0.001).
dIsCussIOn
Prognosis
The majority of the patients (60.5%) referred to the ED 
with chest pain are discharged with NCCP. The prog-
nosis of patients with NCCP is better in terms of survival 
(1-year mortality of 2.3% vs 7.2% and 8.1%, respectively, 
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Table 2 Major adverse cardiac events during 1-year follow-up
Diagnosis at discharge P values
CCP*
(N= 471)†
ACS
(N= 310)†
NCCP‡
(N= 729)†
NCCP-K
(N= 345)†
NCCP-U
(N= 383)† CCP vs NCCP ACS vs NCCP
NCCP-K vs
NCCP-U
MACE, n (%) 39 (8.3) 27 (8.7) 37 (5.1) 13 (3.8) 24 (6.3) 0.026 0.026 0.123
STEMI, n (%) 15 (3.2) 12 (3.9) 19 (2.6) 8 (2.3) 11 (2.9) 0.555 0.273 0.636
NSTEMI, n (%) 15 (3.2) 8 (2.6) 12 (1.6) 5 (1.4) 7 (1.8) 0.079 0.316 0.685
UAP, n (%) 8 (1.7) 6 (1.9) 5 (0.7) 0 (0) 5 (1.3) 0.098 0.072 0.033
CABG or PCI, n (%) 12 (2.5) 9 (2.9) 16 (2.2) 7 (2.0) 9 (2.3) 0.692 0.495 0.764
*CCP group includes patients with ACS.
†Exclusion of 19, 15, 20, 10 and 10 patients from analysis in the CCP, ACS, NCCP, NCCP-K and NCCP-U groups, respectively; in total 25 
due to loss-to-follow-up and 14 due to in-hospital death.
‡NCCP group is a sum of patients with NCCP-K and NCCP-U.
ACS, acute coronary syndrome; MACE, Major adverse cardiac events defined as a combinations of the following: CABG, coronary artery 
bypass graft; CCP, cardiac chest pain; NCCP, non-CCP; NCCP-K, NCCP of known origin; NCCP-U, non-cardiac chest pain group of 
unknown origin; NSTEMI, non-STEMI; PCI, percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction; UAP, unstable 
angina pectoris.
p<0.001) and occurrence of MACE (5.1% vs 8.3% and 
8.7%, respectively, p=0.026) compared with CCP and ACS 
groups. Previous studies showed similar results with 1-year 
mortality rates ranging from 1.4% to 4.2% for patients 
with NCCP and 14% to 19.9% for patients with ACS.4 
Our reported 1-year mortality rate in the ACS group was 
lower than earlier studies, which may be related to the 
introduction of new sensitive markers combined with 
the more sensitive assays for troponins allowing more 
accurate diagnosis and earlier treatment of ACS.4 The 
mortality of the NCCP, of known and unknown origin, 
patients is comparable to the mortality of the general 
population; however, the occurrence of MACE in the 
NCCP, and in particular the patients with NCCP-U is 
considerably high, namely 5.1% and 6.3%, respectively, in 
1 year. Moreover, despite the lower occurrence of MACE 
in the NCCP group, the amount of STEMIs, NSTEMIs, 
UAP and even PCIs or CABG was not statistically signifi-
cantly lower compared with the CCP group, though this 
could be due to the low incidence. The relatively high 
MACE in patients with NCCP may be a consequence of 
the overlapping cardiovascular risk factors at baseline in 
the NCCP and CCP groups. A history of CAD was identi-
fied as a predictive factor for the occurrence of MACE in 
the patients with NCCP. We also found that patients with 
NCCP-U with a history of CAD (or CVD) had a higher 
risk of developing a MACE in the follow-up. This is in 
line with previously reported findings by Ruddox et al,4 
where it was stated that the prognosis of patients with 
NCCP is not necessarily benign due to the pre-existing 
CAD in approximately 40% of these patients. These find-
ings suggest that patients with chest pain and a history 
of CAD should be monitored closely and might benefit 
more from a follow-up to prevent frequent re-presenta-
tions, re-hospitalisations and MACE.
Consultations and interventions
Patients with NCCP did not exceed the amount of visits 
for medical care compared with patients with ischaemic 
heart disease. In the organisation of the Dutch healthcare 
system GPs also play an important role in the manage-
ment of NCCP and thereby decrease the healthcare utili-
sation in secondary healthcare. Healthcare utilisation in 
the primary healthcare setting was not included in this 
study.
Patients with NCCP, in particular the patients with 
NCCP-U, do use a substantial amount of medical resources 
at the cardiology department. The mean amount of 
re-presentations at the ED, duration of outpatient depart-
ment monitoring and visits to the cardiologist of patients 
with NCCP-U exceeds that of patients with NCCP-K. 
Moreover, the amount of cardiac interventions including 
PCI, CABG, CAG and non-invasive imaging are also 
higher in the NCCP-U vs the NCCP-K group. It is believed 
that a lack of explanation for their symptoms may lead to 
psychological distress which drives patients with NCCP-U 
to seek medical advice,3 whereas patients who are given 
a specific diagnosis for their chest pain use less health-
care.6 The higher amount of PCI in the NCCP group may 
be due to incidental findings of coronary artery stenosis 
that is not related to the chest pain complaints. In the 
process, patients with NCCP are exposed to risk and stress 
by unnecessary referral or admission to the hospital and 
the consequential interventions, posing a psychological 
burden on them as well as their families.9 10 In order to 
combat the issues of overcrowding at the ED, the costs of 
healthcare and the exposure of patients to unnecessary 
hospital admissions and diagnostics, it is important to 
improve triage and follow-up of patients with chest pain.9
strengths and limitations
All patients 18 years and older with chest pain referred 
from primary healthcare were included in this study, 
making it an unselected study population with a good 
representation of daily practice at the ED. However, this 
may result in a rather heterogeneous study population.
Furthermore, the study was a single-centre study and 
set at the ED, making it vulnerable for selection bias, with 
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patients mostly referred after contact with a GP. In the 
Netherlands, GPs have a gatekeeper role and patients are 
advised to initially consult their GP for most symptoms. 
Therefore, the patients who are referred to the ED are 
more likely to have cardiovascular risk factors and prior 
history of CAD. As a consequence, our study population 
may have had a higher occurrence of MACE than the 
general population and patients in primary healthcare 
and even than in countries without GPs as gate keepers.
This single-centre study did include all patients referred 
from the region. A selection bias through expertise of the 
centre was not a factor.
Conclusion and recommendations
The majority of patients referred to the ED with chest 
pain are discharged with a non-cardiac diagnosis. The 
prognosis in patients with NCCP is better than patients 
with CCP; however, they are nevertheless at risk for the 
occurrence of MACE due to the presence of cardiovas-
cular risk factors and prior history of CAD at baseline. 
NCCP, and in particular NCCP-U, patients moreover 
use a substantial amount of medical resources. Triage 
during the first presentation with chest pain should be 
improved to minimise unnecessary hospital admissions 
and the consequential healthcare utilisation of patients 
with NCCP while still preventing MACE.
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